RO7017773
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RO7017773, covering 2019-09-30 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) [Phase 2]